Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 10,501 shares at $59.75 ($638K) on 2026-06-16, disclosed to the SEC on 2026-06-18.
Seasonal sale ($638k) by CHIEF EXECUTIVE OFFICER — this insider has traded WGS in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.75 | 2,140 | $128K | 20.0% |
| 2 | $60.83 | 5,932 | $361K | 56.5% |
| 3 | $61.50 | 2,429 | $149K | 23.4% |
| Total | $60.77 avg | 10,501 | $638K | 100% |
| Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |
| WGS | SELL | 2026-03-30 | $5.9M | — | Filing → |